Glucose control and vascular complications in veterans with type 2 diabetes

Cited by (1,057)

Items 301–400 of 1,057

1. Tissue Factor, Blood Coagulation, and Beyond: An Overview
   Arthur J. Chu · 2011 · International Journal of Inflammation
2. Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017
   Theodore H. Wein, M. Patrice Lindsay, Robert Côté, Norine C. Foley, Joseph Berlingieri, Sanjit Kaur Bhogal, Aline Bourgoin, Brian H Buck, Jafna L. Cox, Dion Davidson et al. · 2017 · International Journal of Stroke
3. Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study
   Angus Forbes, Trevor Murrells, Henrietta E. Mulnier, Alan J. Sinclair · 2018 · The Lancet Diabetes & Endocrinology
4. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study
   de Pablos‐Velasco, Pedro, Parhofer, Klaus G, Bradley, Clare, Eschwège, Eveline, Gönder-Frederick, Linda, Maheux, Pierre, Wood, Ian, Simon, Dominique · 2014 · Clinical Endocrinology
5. Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment
   Akif Serhat Balcıoğlu · 2015 · World Journal of Diabetes
6. Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults
   Jerome L. Fleg, Daniel E. Forman, Kathy A. Berra, Vera Bittner, James A. Blumenthal, Michael A. Chen, Susan C. Cheng, Dalane W. Kitzman, Mathew S. Maurer, Michael W. Rich et al. · 2013 · Circulation
7. Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
   Odd Erik Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Dhanji Patel, Hans‐Juergen Woerle · 2012 · Cardiovascular Diabetology
8. American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement
   Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel E. Dagogo-Jack, Michael Davidson, DANIEL F. EINHORN, William Timothy Garvey et al. · 2013 · Endocrine Practice
9. Chronic Hyperglycemia and Glucose Toxicity: Pathology and Clinical Sequelae
   Carlos Campos · 2012 · Postgraduate Medicine
10. 12. Older Adults: Standards of Medical Care in Diabetes—2021
    American Diabetes Association · 2020 · Diabetes Care
11. A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
    Robert C. Frederich, John Hunter Alexander, Fred T. Fiedorek, Mark Donovan, Niklas Berglind, Susan Harris, Roland K. Chen, Robert Wolf, Kenneth W. Mahaffey · 2010 · Postgraduate Medicine
12. Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A randomized clinical trial
    Martínez-Cerón, Elisabet, Barquiel, Beatriz, Bezos, Ana-Maria, Casitas, Raquel, Galera, Raúl, García-Benito, Cristina, Hernanz, Angel, Alonso-Fernández, Alberto, Garcia-Rio, Francisco · 2016 · American Journal of Respiratory and Critical Care Medicine
13. Cardiovascular disease in diabetes, beyond glucose
    Robert H. Eckel, Karin Bornfeldt, Ira J. Goldberg · 2021 · Cell Metabolism
14. 5. Glycemic Targets
    American Diabetes Association · 2015 · Diabetes Care
15. Epigenetics
    Mark E. Cooper, Assam El‐Osta · 2010 · Circulation Research
16. Coronary Artery Disease and Diabetes Mellitus
    Aronson, Doron, Edelman, Elazer R. · 2014 · Cardiology Clinics
17. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
    Papademetriou, Vasilios, Lovato, Laura, Doumas, Michael, Nylen, Eric, Mottl, Amy, Cohen, Robert M., Applegate, William B., Puntakee, Zubin, Yale, Jean Francois, Cushman, William C. · 2015 · Kidney International
18. Minimizing Hypoglycemia in Diabetes
    International Hypoglycaemia Study Group · 2015 · Diabetes Care
19. 13. Older Adults: Standards of Care in Diabetes—2025
    American Diabetes Association Professional Practice Committee, ElSayed, Nuha A., McCoy, Rozalina G., Aleppo, Grazia, Balapattabi, Kirthikaa, Beverly, Elizabeth A., Briggs Early, Kathaleen, Bruemmer, Dennis, Echouffo-Tcheugui, Justin B., Ekhlaspour, Laya et al. · 2025 · Diabetes Care
20. Diabetes and Altered Glucose Metabolism with Aging
    Rita Rastogi Kalyani, Josephine Mary Egan · 2013 · Endocrinology and Metabolism Clinics of North America
21. Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015
    Νικόλαος Παπάνας, Dan Ziegler · 2015 · The Review of Diabetic Studies
22. Autonomic imbalance: prophet of doom or scope for hope?
    Aaron I. Vinik, Raelene E. Maser, Dan Ziegler · 2010 · Diabetic Medicine
23. Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
    Priscilla A. Hollander, Jia Li, Elsie Allen, Roland K. Chen, for the CV181-013 Investigators · 2009 · The Journal of Clinical Endocrinology & Metabolism
24. Link between the renin–angiotensin system and insulin resistance: Implications for cardiovascular disease
    Ming-Sheng Zhou, Ivonne Hernandez Schulman, Qiang Zeng · 2012 · Vascular Medicine
25. Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation
    Wright, Rohana J., Newby, David E., Stirling, David, Ludlam, Christopher A., Macdonald, Ian A., Frier, Brian M. · 2010 · Diabetes Care
26. Glucose, Obesity, Metabolic Syndrome, and Diabetes
    Tamara B. Horwich, Gregg C. Fonarow · 2010 · Journal of the American College of Cardiology
27. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease
    Rodolfo Javier Galindo, Roy W. Beck, Maria Florencia Scioscia, Guillermo E. Umpierrez, Katherine R. Tuttle · 2020 · Endocrine Reviews
28. 6. Glycemic Targets
    American Diabetes Association · 2015 · Diabetes Care
29. Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
    Robert R. Henry, Abraham Michael Lincoff, Sunder Raj D. Mudaliar, Michael A. Rabbia, Cathy Chognot, Matthias Herz · 2009 · The Lancet
30. Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
    Newman, Jonathan D., Schwartzbard, Arthur Z., Weintraub, Howard S., Goldberg, Ira J., Berger, Jeffrey S. · 2017 · Journal of the American College of Cardiology
31. The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations
    Pearl Lee, Jeffrey B. Halter · 2017 · Diabetes Care
32. 13. Older Adults: Standards of Care in Diabetes—2023
    Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana M. Isaacs, Eric L. Johnson et al. · 2022 · Diabetes Care
33. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
    Bianca Hemmingsen, Søren Søgaard Lund, Christian Nyfeldt Gluud, Allan Arthur Vaag, Thomas Almdal, Jørn Wetterslev · 2013 · Cochrane Database of Systematic Reviews · Retracted
34. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials
    Edoardo Mannucci, Matteo Monami, Caterina Lamanna, F. Gori, Niccolò Marchionni · 2009 · Nutrition Metabolism and Cardiovascular Diseases
35. Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice
    Lu Gan, Dina Xie, Jing Liu, Wayne Bond Lau, Theodore A. Christopher, Bernard Lopez, Ling Zhang, Erhe Gao, Walter J. Koch, Xinliang Ma et al. · 2020 · Circulation
36. Thiazolidinedione safety
    Kung, Jacqueline, Henry, Robert R · 2012 · Expert Opinion on Drug Safety
37. Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
    Yoshifumi Saisho · 2014 · International Journal of Molecular Sciences
38. <scp>Glucagon‐like peptide‐1 receptor agonists</scp> improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
    Bray, Jonathan J. H., Foster‐Davies, Harri, Salem, Ahmed, Hoole, Amy L., Obaid, Daniel R., Halcox, Julian P. J., Stephens, Jeffrey W. · 2021 · Diabetes Obesity and Metabolism
39. Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus
    David M. Maahs, Stephen R. Daniels, Sarah D. de Ferranti, Helén L. Dichek, Joseph T. Flynn, Benjamin I. Goldstein, Aaron S. Kelly, Kristen J. Nadeau, Pamela A. Martyn-Nemeth, Stavroula K. Osganian et al. · 2014 · Circulation
40. Diabetic kidney disease: from physiology to therapeutics
    Carmen Mora Fernández, V. Domínguez-Pimentel, Mercedes Muros de Fuentes, José Luis Górriz, Alberto Martínez‐Castelao, Juan F. Navarro‐González · 2014 · The Journal of Physiology
41. Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes
    The ACCORD Study Group · 2016 · Diabetes Care
42. Combination therapy with <scp>GLP</scp> ‐1 receptor agonist and <scp>SGLT2</scp> inhibitor
    DeFronzo, Ralph A. · 2017 · Diabetes, Obesity and Metabolism
43. Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
    Miriam Longo, Giuseppe Bellastella, Maria Ida Maiorino, Juris Jendrik Meier, Katherine Esposito, Dario Giugliano · 2019 · Frontiers in Endocrinology
44. Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study
    Caroline S. Fox · 2010 · Trends in Cardiovascular Medicine
45. Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies
    Carlo Alberto Ricciardi, Luigi Gnudi · 2021 · Metabolism
46. Glycaemic control in type 2 diabetes: Targets and new therapies
    Abd A. Tahrani, Milan K. Piya, Amy Kennedy, Anthony H Barnett · 2009 · Pharmacology & Therapeutics
47. Cerebrovascular Complications of Diabetes: Focus on Stroke
    Adviye Ergul, Aisha I. Kelly-Cobbs, Maha Abdalla, Susan C. Fagan · 2012 · Endocrine Metabolic & Immune Disorders - Drug Targets
48. Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes
    Joni Ricks, Miklos Zsolt Molnar, Csaba Pal Kovesdy, Anuja Pradip Shah, Allen R. Nissenson, Mark E. Williams, Kamyar Kalantar‐Zadeh · 2012 · Diabetes
49. American Geriatrics Society Identifies Five Things That Healthcare Providers and Patients Should Question
    AGS Choosing Wisely Workgroup · 2013 · Journal of the American Geriatrics Society
50. Autonomic Neuropathy in Diabetes Mellitus
    Verrotti, Alberto, Prezioso, Giovanni, Scattoni, Raffaella, Chiarelli, Francesco · 2014 · Frontiers in Endocrinology
51. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis
    Davide Castagno, Jonathan Baird-Gunning, Pardeep S. Jhund, Giuseppe Biondi‐Zoccai, Michael Ross MacDonald, Mark Colquhoun Petrie, Fiorenzo Gaïta, John J.V. McMurray · 2011 · American Heart Journal
52. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial
    Joline W. J. Beulens, Anushka A Patel, Johannes R. Vingerling, John Kennedy Cruickshank, Alun David Hughes, Alice V. Stanton, J. Lu, Simon Thom, Diederick E. Grobbee, Ronald P. Stolk · 2009 · Diabetologia
53. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study
    2014 · The Lancet Diabetes &amp; Endocrinology
54. Insulin for glycaemic control in acute ischaemic stroke
    Fernanda Bellolio, Rachel M. Gilmore, Latha Ganti · 2014 · Cochrane Database of Systematic Reviews
55. Pharmacotherapy of type 2 diabetes: An update
    Jagriti Upadhyay, Stergios A. Pοlyzos, Nikolaos Perakakis, Bindiya Thakkar, Stavroula Α. Paschou, Niki Katsiki, PATRICIA C. UNDERWOOD, Kyung‐Hee Park, Jochen Seufert, Eun Seok Kang et al. · 2017 · Metabolism
56. Precision medicine in the management of type 2 diabetes
    Anna L. Gloyn, Daniel J. Drucker · 2018 · The Lancet Diabetes & Endocrinology
57. Defining Medical Futility and Improving Medical Care
    Lawrence J. Schneiderman · 2011 · Journal of Bioethical Inquiry
58. Active Care Management Supported by Home Telemonitoring in Veterans With Type 2 Diabetes
    Roslyn A. Stone, R Harsha Rao, Mary Ann Sevick, Chunrong Cheng, Linda J. Hough, David S. Macpherson, Carol M. Franko, Rebecca A. Anglin, David Scott Obrosky, Frederick R. DeRubertis · 2009 · Diabetes Care
59. Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction
    Tatsuya Maruhashi, Yukihito Higashi · 2021 · Antioxidants
60. Guideline for management of postmeal glucose in diabetes
    1 · 2013 · Diabetes Research and Clinical Practice
61. Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
    Peter D. Reaven, THOMAS E. MORITZ, Dawn C. Schwenke, Robert J. Anderson, Michael H. Criqui, Robert Detrano, Nicholas Emanuele, Moti Kayshap, Jennifer B. Marks, Sunder Raj D. Mudaliar et al. · 2009 · Diabetes
62. Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
    Khunti, Sachin, Khunti, Kamlesh, Seidu, Samuel · 2019 · Therapeutic Advances in Endocrinology and Metabolism
63. The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
    Marcel H.A. Muskiet, Mark M. Smits, Linde M. Morsink, Michaëla Diamant · 2013 · Nature Reviews Nephrology
64. Diabetic Kidney Disease
    Ryan Bonner, Oltjon Albajrami, James C. Hudspeth, Ashish Upadhyay · 2020 · Primary Care Clinics in Office Practice
65. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
    Eeg‐Olofsson, K., Cederholm, J., Nilsson, P. M., Zethelius, B., Svensson, A.‐M., Gudbjörnsdóttir, S., Eliasson, B. · 2010 · Journal of Internal Medicine
66. Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence
    Rodríguez-Gutiérrez, René, Montori, Victor M. · 2016 · Circulation: Cardiovascular Quality and Outcomes
67. EADSG Guidelines: Insulin Therapy in Diabetes
    Silver, Bahendeka, Ramaiya, Kaushik, Andrew, Swai Babu, Fredrick, Otieno, Bajaj, Sarita, Kalra, Sanjay, Charlotte, Bavuma M., Claudine, Karigire, Makhoba, Anthony · 2018 · Diabetes Therapy
68. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities
    Boucai, Laura, Southern, William N., Zonszein, Joel · 2011 · The American Journal of Medicine
69. Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy
    Josie Carmichael, Hassan Fadavi, Fukashi Ishibashi, Angela C. Shore, Mitra Tavakoli · 2021 · Frontiers in Endocrinology
70. Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
    Funk, Steven Daniel, Yurdagul, Arif, Orr, A. Wayne · 2012 · International Journal of Vascular Medicine
71. A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes
    McKenzie, Amy L, Hallberg, Sarah J, Creighton, Brent C, Volk, Brittanie M, Link, Theresa M, Abner, Marcy K, Glon, Roberta M, McCarter, James P, Volek, Jeff S, Phinney, Stephen D · 2017 · JMIR Diabetes
72. Glycemic Management of Type 2 Diabetes Mellitus
    Faramarz Ismail‐Beigi · 2012 · New England Journal of Medicine
73. Diabetes mellitus and stroke: A clinical update
    Tun, Nyo Nyo, Arunagirinathan, Ganesan, Munshi, Sunil K, Pappachan, Joseph M · 2017 · World Journal of Diabetes
74. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation
    N Waugh, Eleanor Cummins, Pamela Royle, Christine Clar, Meaghan Marien, Bernd Richter, Sam Philip · 2010 · Health Technology Assessment
75. Insulin therapy and hypoglycemia
    McCall, Anthony L. · 2012 · Endocrinology and Metabolism Clinics of North America
76. Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis
    Christian Sonesson, Peter A. Johansson, EVA K. JOHNSSON, Ingrid A. M. Gause‐Nilsson · 2016 · Cardiovascular Diabetology
77. Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
    Connie B. Newman, Michael Joseph Blaha, Jeffrey B. Boord, Bertrand Cariou, Alan Chait, Henry G. Fein, Henry N. Ginsberg, Ira J. Goldberg, Mohammad Hassan Murad, Savitha Subramanian et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
78. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study
    Ronald B Goldberg, Trevor John Orchard, Jill P. Crandall, Edward J. Boyko, Matthew Jay Budoff, Dana Dabelea, Kishore M. Gadde, William C. Knowler, Christine G. Lee, David M. Nathan et al. · 2022 · Circulation
79. Intensive glycemic control and cardiovascular disease: an update
    Aparna Brown, L. Raymond Reynolds, Dennis Bruemmer · 2010 · Nature Reviews Cardiology
80. Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes
    Jin Joo Park · 2021 · Diabetes & Metabolism Journal
81. Coronary Artery Disease and Type 2 Diabetes Mellitus
    Ryo Naito, Katsumi Miyauchi · 2017 · International Heart Journal
82. Interactions between kidney disease and diabetes: dangerous liaisons
    Roberto Pecoits‐Filho, Hugo Abensur, Carolina de Castro Rocha Betônico, Alisson Diego Machado, Erika Bezerra Parente, Márcia Silva Queiroz, João Eduardo Nunes Salles, Silvia Titan, Sérgio Alberto Cunha Vencio · 2016 · Diabetology & Metabolic Syndrome
83. Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes
    Sheldon Greenfield, John Billimek, Fabio Pellegrini, Monica Franciosi, Giorgia De Berardis, Antonio Nicolucci, Sherrie H. Kaplan · 2009 · Annals of Internal Medicine
84. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020
    Gladstone, David J., Lindsay, M. Patrice, Douketis, James, Smith, Eric E., Dowlatshahi, Dar, Wein, Theodore, Bourgoin, Aline, Cox, Jafna, Falconer, John B., Graham, Brett R. et al. · 2022 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
85. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes
    David M. Nathan · 2009 · Diabetes Care
86. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
    on behalf of the DEVOTE Study Group, Bernard Zinman, Steven P. Marso, Neil R Poulter, Scott S. Emerson, Thomas Rudolf Pieber, Richard E. Pratley, Martin Lange, Kirstine Brown‐Frandsen, Alan Charles Moses et al. · 2017 · Diabetologia
87. Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
    Daniel Lorber · 2014 · Diabetes Metabolic Syndrome and Obesity
88. The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes
    Louis Monnier, Anne Wojtusciszyn, C Colette, David R. Owens · 2011 · Diabetes Technology & Therapeutics
89. Hydrolyzed Infant Formula and Early β-Cell Autoimmunity
    Mikael Knip, Hans K. Åkerblom, DOROTHY J. BECKER, Hans-Michael Dosch, John Dupre, William Donald Fraser, Neville J. Howard, Jorma Ilonen, Jeffrey P. Krischer, Olga Kordonouri et al. · 2014 · JAMA
90. Revisiting the links between glycaemia, diabetes and cardiovascular disease
    Sattar, N. · 2013 · Diabetologia
91. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus
    Muhammad A Abdul‐Ghani, Luke Norton, Ralph Anthony DeFronzo · 2015 · American Journal of Physiology-Renal Physiology
92. Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
    Nikolaus Marx, Darren K. McGuire · 2016 · European Heart Journal
93. Sulfonylureas: A New Look at Old Therapy
    Peter M. Thulé, Guillermo E. Umpierrez · 2014 · Current Diabetes Reports
94. Advances in the Treatment of Type 2 Diabetes Mellitus
    Zafar H. Israili · 2010 · American Journal of Therapeutics
95. Pain in Chronic Kidney Disease: A Scoping Review
    Sara N. Davison, Holly M. Koncicki, Frank Patrick Brennan · 2014 · Seminars in Dialysis
96. Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study
    O'Brien, Rebecca, Johnson, Eric, Haneuse, Sebastien, Coleman, Karen J., O'Connor, Patrick J., Fisher, David P., Sidney, Stephen, Bogart, Andy, Theis, Mary Kay, Anau, Jane et al. · 2018 · Annals of Internal Medicine
97. The importance of hypoglycemia in diabetic patients
    Gita Shafiee, Mohammad Reza Mohajeri‐Tehrani, Mohammad Pajouhi, Bagher A. Larijani · 2012 · Journal of Diabetes & Metabolic Disorders
98. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
    F. Piepoli, Massimo · 2017 · International Journal of Behavioral Medicine
99. Assessing the cardio–cerebrovascular safety of vildagliptin: meta‐analysis of adjudicated events from a large Phase III type 2 diabetes population
    Anja Schweizer, Sylvie Dejager, James Edward Foley, A. Couturier, Monica Ligueros‐Saylan, Wolfgang Kothny · 2010 · Diabetes Obesity and Metabolism
100. 13. Older Adults: <i>Standards of Care in Diabetes—2024</i>
     American Diabetes Association Professional Practice Committee, ElSayed, Nuha A., Aleppo, Grazia, Bannuru, Raveendhara R., Bruemmer, Dennis, Collins, Billy S., Ekhlaspour, Laya, Hilliard, Marisa E., Johnson, Eric L., Khunti, Kamlesh et al. · 2024 · Diabetes Care